Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Fish and Richardson
UBS
Citi
Dow
Daiichi Sankyo
Moodys
Johnson and Johnson

Generated: May 27, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,932,247

« Back to Dashboard

Summary for Patent: 5,932,247
Title: Pharmaceutical composition for piperidinoalkanol compounds
Abstract:The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.
Inventor(s): Ortyl; Thomas T. (Overland Park, KS), Skultety; Paul F. (Leawood, KS), Mitchell; Kristen C. (Lee's Summit, MO), Phadke; Deepak S. (Olathe, KS), Attarchi; Faraneh (Kansas City, MO), Pierce; Marguerite L. (Fairway, KS), Schoeneman; Aaron W. (Lee's Summit, MO), Schnitz; Joseph M. (Kansas City, MO)
Assignee: Hoechst Marion Roussel, Inc. (Cincinnati, OH)
Application Number:08/948,005
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,932,247
Patent Claims: 1. A pharmaceutical composition in solid unit dosage form prepared by a process comprising blending together a compound of the formula: ##STR10## wherein X is a number ranging from about zero to 5, and the individual optical isomers thereof, with microcrystalline cellulose, lactose and pregelatinized starch; adding a solution of gelatin in water mixing; drying and milling the mixture; and adding croscarmellose sodium with mixing, wherein the resulting mixture is filled into capsules.

2. A pharmaceutical composition in solid form wherein croscarmellose sodium, microcrystalline cellulose, lactose, pregelatinized starch, gelatin and magnesium stearate are present in amounts of about 4.8%, 33.7%, 33.7%, 9.6%, 3.5% and 0.5%, respectively, by weight of the composition, wherein the final mixture is pressed into a tablet from which the quantity of compound of the formula: ##STR11## wherein X is a number ranging from about zero to 5, and the individual optical isomers thereof, dissolved in 45 minutes, is not less than 75% of label in water at about 37.degree. C. and about 50 rpm when measured using USP Apparatus 2.

3. A pharmaceutical composition in solid form wherein croscarmellose sodium, microcrystalline cellulose, lactose, pregelatinized starach, gelatin and magnesium stearate are present in amounts of about 4.8%, 25.7%, 25.7%, 9.6%, 3.5% and 0.75% respectively, by weight of the composition wherein the final mixture is pressed into a tablet from which the quantity of compound of the formula: ##STR12## wherein X is a number ranging from about zero to 5, and the individual optical isomers thereof, dissolved in 45 minutes, is not less than 75% of label in 0.001 N aqueous hydrochloric acid at abaout 37.degree. C. and about 50 rpm when measured using USP Apparatus 2.

4. A pharmaceutical composition in solid form wherein croscarmellose sodium, microcrystalline cellulose, pregelatinized starch, and magnesium stearate are present in amounts of about 6%, 33.3%, 30% and 0.75% respectively, by weight of the composition wherein the final mixture is pressed into a tabalet from which the quantity of compound of the formula: ##STR13## wherein X is a number ranging from about zero to 5, and the individual optical isomers thereof, dissolved in 45 minutes, is not less than 75% of label in 0.001 N aqueous hydrochloric acid at about 37.degree. C. and about 50 rpm when measured using USP Apparatus 2.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Baxter
Queensland Health
Cerilliant
Federal Trade Commission
AstraZeneca
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.